Navigation Links
Pharmaceutical Execs to Gain Manufacturing Insights from Top Aerospace, Automotive and Other Non-Pharma Industries at Unique ISPE Event
Date:1/31/2013

TAMPA, Fla., Jan. 31, 2013 /PRNewswire-USNewswire/ -- ISPE announced today that it will bring together top executives from the aerospace, automotive and other non-pharmaceutical industries to share manufacturing and quality innovations in an Executive Forum in Philadelphia, Penn. USA, 2-3 April 2013. Attendees will receive a rare opportunity to convene with world-class leaders and to gain industry-advancing insight related to lifecycle development and management, best manufacturing practices, continuous manufacturing, supplier development, quality management systems and leadership.

(Logo:  http://photos.prnewswire.com/prnh/20120912/DC73253LOGO)

"ISPE is dedicated to leading the pharmaceutical industry by addressing significant issues that have the greatest potential to enhance manufacturing and production, quality, engineering and regulatory matters throughout the product lifecycle. Through this all-new event, ISPE will facilitate executive-level discussions that go beyond best practices in the pharmaceutical industry, featuring presentations from other industries facing similar manufacturing, quality and global integration challenges," said Nancy Berg , ISPE President and CEO. "The discussions planned for this conference will help Members, pharmaceutical companies and their suppliers translate solutions and lessons learned from other industries into their own operations."

Notable speakers at this conference include:

  • Janet Woodcock , Director, Center for Drug Evaluation and Research (CDER), FDA, USA
  • Craig Kennedy , Senior Vice President, Supply Chain Man
    '/>"/>

SOURCE ISPE
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
2. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
3. Pharmaceutical Industry Service Company Awarded The UKs Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
4. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
5. Simcere Pharmaceutical Group to Announce First Quarter 2012 Financial Results on Wednesday, May 9, 2012
6. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
7. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
8. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
9. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
10. Icahn Issues Statement Regarding Amylin Pharmaceuticals
11. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... 2014 Moms are ready to live the ... and their kids, according to the results of the ... Go Mobile for Moms, the latest installment in BabyCenter,s ... 1 pregnancy and parenting web and mobile destination worldwide, ... moms surveyed say they can,t think of a reason ...
(Date:10/22/2014)... , Oct. 22, 2014  Paper Pak ... has developed APLS ® Body Guard Bio, ... the spread of bacteria and virus while protecting ... Body Guard Bio features a rugged, external nylon ... that create a leak-proof inner chamber that contains ...
(Date:10/22/2014)... , Oct. 22, 2014 AVACEN Medical ... device received 510 (k) OTC clearance by the U.S. ... 100 to be marketed over the Internet for: ... muscle spasms; and minor strains and sprains . ... The AVACEN 100 (MSRP $2495) is a sophisticated medical ...
Breaking Medicine Technology:BabyCenter Finds Mom Ready to Live the "Measured Life" in its U.S. Mobile Mom 2014 Report: Health & Fitness Go Mobile for Moms 2BabyCenter Finds Mom Ready to Live the "Measured Life" in its U.S. Mobile Mom 2014 Report: Health & Fitness Go Mobile for Moms 3BabyCenter Finds Mom Ready to Live the "Measured Life" in its U.S. Mobile Mom 2014 Report: Health & Fitness Go Mobile for Moms 4New, State-Of-The-Art Body Bag Minimizes The Spread Of Bacteria And Virus 2AVACEN Medical Announces FDA Clearance of First Medical Device with Internal Game Mode 2
... PARSIPPANY, N.J. , Jan. 14 As ... market, the company has announced the addition of three Vice ... these positions bring a deep knowledge of the spine and ... distribution networks in their respective areas.   , Randy ...
... , HORSHAM, Pa. , ... 3 clinical study comparing the efficacy and safety of STELARA™ ... severe plaque psoriasis appear today in The New England ... clinical response with both doses of STELARA than with etanercept ...
Cached Medicine Technology:Custom Spine Announces the Expansion of its Sales Management Team 2STELARA(TM) Shows Greater Efficacy Than Etanercept for Treatment of Moderate to Severe Plaque Psoriasis: Phase 3 Comparator Study Published in The New England Journal of Medicine 2STELARA(TM) Shows Greater Efficacy Than Etanercept for Treatment of Moderate to Severe Plaque Psoriasis: Phase 3 Comparator Study Published in The New England Journal of Medicine 3STELARA(TM) Shows Greater Efficacy Than Etanercept for Treatment of Moderate to Severe Plaque Psoriasis: Phase 3 Comparator Study Published in The New England Journal of Medicine 4STELARA(TM) Shows Greater Efficacy Than Etanercept for Treatment of Moderate to Severe Plaque Psoriasis: Phase 3 Comparator Study Published in The New England Journal of Medicine 5STELARA(TM) Shows Greater Efficacy Than Etanercept for Treatment of Moderate to Severe Plaque Psoriasis: Phase 3 Comparator Study Published in The New England Journal of Medicine 6STELARA(TM) Shows Greater Efficacy Than Etanercept for Treatment of Moderate to Severe Plaque Psoriasis: Phase 3 Comparator Study Published in The New England Journal of Medicine 7STELARA(TM) Shows Greater Efficacy Than Etanercept for Treatment of Moderate to Severe Plaque Psoriasis: Phase 3 Comparator Study Published in The New England Journal of Medicine 8STELARA(TM) Shows Greater Efficacy Than Etanercept for Treatment of Moderate to Severe Plaque Psoriasis: Phase 3 Comparator Study Published in The New England Journal of Medicine 9
(Date:10/22/2014)... October 22, 2014 Although there are only 24 ... for many people who have trouble finding time within their busy ... exercise for long periods of time to get in shape. Here ... while on the go. , Change Up Your Commute , ... work to add some exercise into your daily routine. If you ...
(Date:10/22/2014)... Steven Reinberg HealthDay Reporter , ... add weight and length may be showing a genetic propensity ... adults, certain genes have been linked to increased body fat, ... fat and lean muscle, the researchers said. At 1 ... By ages 2 and 3, however, these genes were linked ...
(Date:10/22/2014)... HealthDay Reporter TUESDAY, Oct. 21, ... vitro fertilization (IVF) -- the incubation of embryos in a ... inside the vagina, new research suggests. Scientists from the ... INVOcell, might sharply cut costs for pricey IVF procedures among ... to those who don,t live near big-city assisted reproduction centers, ...
(Date:10/20/2014)... The newly updated Worldwide Medical Market ... of facts, figures and forecasts on the global medical ... forecast categories the Worldwide Medical Market Forecasts to ... views on the worldwide medical market to reveal key ... you data for 2010-2019, covering each country market individually, ...
(Date:10/20/2014)... ASCNYC (ascnyc.org) is a New ... Yorkers living with HIV/AIDS and other chronic conditions ... and self-sufficiency. Each year, ASCNYC spotlights selected “Positive ... their tireless efforts. , Savills Studley ... been selected as this year’s honoree for sharing ...
Breaking Medicine News(10 mins):Health News:HealthGuideMD Presents Ways to Improve Your Exercise and Fitness 2Health News:Tall, Heavy 1-Year-Olds May Be at Risk for Obesity Later, Study Finds 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 3Health News:Experimental Infertility Treatment Seems Effective, Cheaper 4Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 2Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 3Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 4Health News:Savills Studley's Marc Shapses To Be Honored as 2014 "Positive Changemaker" by ASCNYC 2Health News:Savills Studley's Marc Shapses To Be Honored as 2014 "Positive Changemaker" by ASCNYC 3
... of Medicare recipients undergoing treatment for retinal conditions nearly ... the types of procedures most commonly performed, according to ... of Ophthalmology , one of the JAMA/Archives journals. ... both age-related macular degeneration (AMD) and diabetic retinopathy account ...
... symptoms associated with cancer symptoms often unrecognized ... of cancers regardless of whether the patient is ... survivor, according to researchers from the Regenstrief Institute ... nursing. Common symptoms include fatigue, pain, weakness, ...
... News) -- Women with epilepsy may be at increased risk of ... included 375 women who planned to have a child, average age ... to 10 years. During the study period, 62 percent of the ... epilepsy was more than twice the 15 percent rate in the ...
... By Steven Reinberg HealthDay Reporter , SUNDAY, Oct. ... to play a role in the propensity for obesity. ... the Oct. 10 online edition of Nature Genetics . ... gene variants linked to obesity and confirmed the involvement of ...
... the receipt of breast cancer care persist despite accounting ... is the conclusion of a study published early online ... American Cancer Society. The findings suggest that greater efforts ... care and to ensure that all affected women receive ...
... , UCSF Chancellor Susan Desmond-Hellmann, MD, MPH, will ... Arts and Sciences, alongside some of the world,s ... Desmond-Hellmann, a renowned oncologist and biotechnology ... biomedical research institution, was among five members of ...
Cached Medicine News:Health News:Treatment of retinal conditions appears to have changed significantly in previous decade 2Health News:Physical symptoms prevalent no matter what stage of cancer including remission 2Health News:Study Sees Link Between Epilepsy, Infertility 2Health News:Researchers Pinpoint Array of Obesity Genes 2Health News:Researchers Pinpoint Array of Obesity Genes 3Health News:Insurance and socioeconomic status do not explain racial disparities in breast cancer care 2Health News:UCSF Chancellor inducted into Academy of Arts and Sciences 2Health News:UCSF Chancellor inducted into Academy of Arts and Sciences 3
Lyphochek Assayed Chemistry Control requires no special diluent and has good reconstituted stability for enzymes and CO2. It is assayed for most major instruments and methodologies....
Lyphochek Benzo/TCA Control Set A is ideal for monitoring HPLC methods for identification and quantitation of benzodiazepines and tricyclic antidepressant drugs....
Lyphochek Benzo/TCA Control Set B is ideal for monitoring HPLC methods for identification and quantitation of benzodiazepines and antidepressant drugs....
Lyphochek Therapeutic Drug Monitoring Control (TDM) contains over 40 analytes with assayed values at three clinically significant levels....
Medicine Products: